The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
nilotinib · Tablet
6 marketed package NDCs · 3 active manufacturers
Most dispensed: 150 mg · Capsule · #4 blister packs/carton / 28 capsule in 1 blister pack · 200 mg · Capsule · #4 blister packs/carton / 28 capsule in 1 blister pack
What changed in the last 90 days
Every detected change for nilotinib, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- CavhanzaAug 12, 2026Mfr exitedCycle Pharmaceuticals Ltd · nilotinib
- CavhanzaAug 12, 2026Mfr exitedCycle Pharmaceuticals Ltd · nilotinib
- CavhanzaJul 22, 2026Mfr enteredCycle Pharmaceuticals Ltd · nilotinib
- CavhanzaJul 22, 2026Mfr enteredCycle Pharmaceuticals Ltd · nilotinib
- CavhanzaJul 22, 2026New productCycle Pharmaceuticals Ltd
- CavhanzaJul 22, 2026New productCycle Pharmaceuticals Ltd
Same drug class
Other molecules FDA puts in Kinase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Nilotinib in shortage right now?
- No. FDA does not currently list Nilotinib in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Nilotinib?
- 17 companies have marketed Nilotinib in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.